Skip to content
Black Friday — 30% OFFFree shipping on orders of A$99 or more
  1. Home
  2. Weight Management & Metabolism
  3. CagriSema
Weight Management

CagriSema

Cagrilintide + semaglutide · Investigational combination

An investigational once-weekly combination of cagrilintide and semaglutide.

Original price was: A$265.Current price is: A$185.50.

Available on request in Australia

Ask an advisor
An advisor contacts you and the partner pharmacy checks whether and how it can proceed. A valid prescription, or an assessment through an authorised telemedicine service, may be required.
  • Partner pharmacy
  • Personal assistance
  • Discreet delivery

Shipping & Delivery

  • Normally dispatched within 24 hours of payment confirmation.
  • USPS Regular Shipping · A$11.95 · Approx. 3–5 business days
  • FedEx 2 Days Delivery · A$28.99 · Approx. 2 business days
  • FedEx Overnight Delivery · A$40.99 · Approx. 1 business day

For research use only.

Not intended for human or animal consumption, nor for medical, personal or diagnostic use. By purchasing this product, you confirm that you are qualified to handle research materials.

Research status

What is known so far

CagriSema combines cagrilintide, a long-acting amylin analogue, with the GLP‑1 receptor agonist semaglutide in a once-weekly injection. It is being studied in clinical trials and has no marketing authorisation.

It has no marketing authorisation as a medicine in this market. This page summarises the state of research and does not describe proven clinical benefits.

Documents

Product information

Patient information leafletNot available: not an authorised medicine
Summary of Product CharacteristicsNot available: not an authorised medicine
Original price was: A$265.Current price is: A$185.50.